Cardio toxicity advances in pharmacogenomics and personalized medicine
Cardio toxicity the potential for drugs and other substances to cause damage
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Cardio toxicity the potential for drugs and other substances to cause damage
The aim of this study was to assess premature rupture of membranes
adverse reactions caused by using programmed cell death-1/programmed cell death ligand-1(PD-1/PD-L1) inhibitors were evaluated. PD-1 is an immune checkpoint receptor which expresses
The cycle of modified cell death, or apoptosis, is by and large
Background: The present study was conducted to examine apoptotic, cytotoxic and necrotic
Rituximab has been revolutionized and validated CD20 targeting monoclonal antibody. Although, it
Research into the area of exercise-induced lymphocyte apoptosis is a relatively
Immune Checkpoint Inhibitor (ICI), especially programmed cell-death protein 1 ligand 1 (PD-L1)/PD-L2 and the programmed cell-death protein 1 (PD-1) axis inhibitor, has become
death pathways. The major forms of cell death include apoptosis, necrosis, autophagy, and programmed necrosis [1,. Apoptosis, often referred to as programmed cell death, plays a crucial role in embryogenesis…
using a panel of monoclonal antibodies and revealed negative stain for CD163, CD68, programmed cell death (PD-1)/Programmed cell Death l Ligand 1(PD-L1), and FoxP3. Chemotherapy followed
studies have demonstrated their roles in regulating cell death pathway. New concept of programmed cell death includes autophagy and necroptosis, two independent pathway of programmed cell death beside apoptosis
virus 1 infection, erythroblastic oncogene B signaling pathway, colorectal cancer, longevity regulating pathway, programmed cell death ligand expression and programmed cell death protein pathway in cancer (p<0.05)…
with 2 to 5 estimated to be directly attributable to immunotherapy.4, 5 Programmed cell death protein 1 or programmed cell death ligand 1 signaling pathway, or the cytotoxic T lymphocyte
initiated by ligand receptor interaction. Anti-tumor immunity is enhanced by binding programmed cell death protein 1 and programmed cell death ligand 1.Cytotoxic drugs are considered as potential partners
checkpoint programmed cell death protein 1 (PD-1)/ programmed death-ligand 1(PD-L1) plays an important role in cancer proliferation. Thyroid hormone, L-thyroxine (T4), induces the expression
homeostasis to maintain proper tissue architecture and function. Two major forms of cell death, apoptosis, and programmed necrosis, play crucial roles in these processes. The immune system, traditionally known ... role…
that loss of BRCA2 confers cells resistance to anoikis, a peculiar form of programmed cell death (PCD) necessary for cancer cells to colonize distal sites during the metastatic process. This ... CRPC cells by activating…
many forms of solid tumors. Most immune checkpoint inhibitors target the PD (Programmed Cell Death)-1/PD-L1 (programmed cell death ligand 1) pathway. These agents are generally well tolerated
free radical induced cell death. Summarizing the co-administration of these compounds induce programmed cell death, probably by disrupting the cellular redox homeostasis, so further studies of the effect
administration of antibodies blocking the immune checkpoint molecules programmed cell death protein 1 (PD-1) or programmed cell death 1 ligand 1 (PD-L1) has evolved as one of major
Immune checkpoint inhibitors include programmed cell death-1 receptor inhibitors (PD-1), programmed cell death ligand-1 inhibitors and CTLA-4 inhibitors and are novel treatment against certain cancers like
immunity, such as cytotoxic T[1]lymphocyte Antigen 4 (CTLA-4) and Programmed Cell Death 1 (PD-1) or its ligand, Programmed Cell Death Ligand 1 (PD-L1). Immune checkpoint
regulators of immunity, such as cytotoxic T-lymphocyte Antigen 4 (CTLA-4) and Programmed Cell Death 1 (PD-1) or its ligand, Programmed Cell Death Ligand 1 (PD-L1). Immune
impaired by tumor cell immunosuppression of host T-cell antitumor activity through the programmed cell death 1 ligand (PD-L1) and programmed cell death receptor
For authors and organisers
Find the right journal for your paper and submit your manuscript.